Metraipolis › archive › dc_ca90ecd64bbe

A clinical SARS-CoV-2 Mpro inhibitor blocks replication of multiple enteroviruses and confers oral in vivo protection in animal models — Europe PMC PMID:41811867

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41811867
DOI: 10.1371/journal.ppat.1014051
License (as archived): solo-consultazione
Archived: 2026-11-04T20:04:13.045Z
SHA-256 of the archived text: 1d740949f63f34d82b0b94595a45b506afd82986d0b13a7f607f4b770d65d122
Stable URL of this page: https://metraipolis.com/documento/dc_ca90ecd64bbe

How to cite

A clinical SARS-CoV-2 Mpro inhibitor blocks replication of multiple enteroviruses and confers oral in vivo protection in animal models — Europe PMC PMID:41811867 — Europe PMC (en), https://europepmc.org/article/MED/41811867 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca90ecd64bbe (Metraipolis archive dc_ca90ecd64bbe, sha256 1d740949f63f34d82b0b94595a45b506afd82986d0b13a7f607f4b770d65d122)

BibTeX

@misc{dcca90ecd64bbe,
  title = {A clinical SARS-CoV-2 Mpro inhibitor blocks replication of multiple enteroviruses and confers oral in vivo protection in animal models — Europe PMC PMID:41811867},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41811867},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca90ecd64bbe; sha256 1d740949f63f34d82b0b94595a45b506afd82986d0b13a7f607f4b770d65d122},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41811867. Agents can read the archived copy with the MCP tool read_document.